Cdymax Pharma has been slapped with a warning letter from the FDA outlining two observations against the Bangalore, India-based API maker, both linked to testing shortfalls. The letter comes in ...
Global High Potency API CDMOs Market OverviewThe global High Potency API CDMOs market is projected to achieve strong single-digit growth by 2027, driven by a rapid surge in demand for oncology ...
C2 PHARMA, the global leader in ophthalmic APIs announces the launch of its latest API, timolol maleate. The validation campaign for timolol maleate was completed in August 2025, and a Certificate of ...
What not to do with active pharmaceutical ingredient (API) batch records? Tear them out of a company logbook ahead of an FDA inspection, for one. Earlier this month, Indian drugmaker Indiana Chem-Port ...
BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product life cycle, today reported that its unique mix of active pharmaceutical ...
Pharmaceutical Technology® spoke with Dr. Weite Oldenziel, CEO of Ofichem, before CPHI Frankfurt 2025 to get his perspective on the API market and why it is important to qualify API suppliers. APIs ...
Pharmaceuticals are developed, designed, and commonly manufactured in laboratory settings. Laboratory testing is an essential need in almost every stage of pharmaceutical production and R&D, from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback